Elanco Animal Health Inc financial data

Symbol
ELAN on NYSE
Location
2500 Innovation Way, Greenfield, IN
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 257 % -12.5%
Quick Ratio 122 % -6.54%
Debt-to-equity 104 % -21%
Return On Equity 6.74 %
Return On Assets 3.3 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 497M shares +0.5%
Common Stock, Shares, Outstanding 497M shares +0.5%
Entity Public Float 7.1B USD +44.9%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 497M shares +0.49%
Weighted Average Number of Shares Outstanding, Diluted 500M shares +1.19%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 4.48B USD -0.18%
Research and Development Expense 354M USD +3.81%
Costs and Expenses 3.95B USD -29.6%
Nonoperating Income (Expense) -46M USD +25.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 593M USD
Income Tax Expense (Benefit) 159M USD +1345%
Net Income (Loss) Attributable to Parent 434M USD
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 539M USD +29.6%
Accounts Receivable, after Allowance for Credit Loss, Current 989M USD -1%
Inventory, Net 1.67B USD +3.66%
Assets, Current 3.61B USD -9.9%
Property, Plant and Equipment, Net 1.36B USD +43%
Operating Lease, Right-of-Use Asset 122M USD -12.9%
Intangible Assets, Net (Excluding Goodwill) 3.71B USD -7.38%
Goodwill 4.76B USD +6.21%
Other Assets, Noncurrent 308M USD -4.94%
Assets 13.7B USD -0.16%
Accounts Payable, Current 368M USD +26.5%
Employee-related Liabilities, Current 177M USD +12.7%
Contract with Customer, Liability, Current 367M USD +3.09%
Liabilities, Current 1.39B USD +1.61%
Long-term Debt and Lease Obligation 4.15B USD
Deferred Income Tax Liabilities, Net 496M USD -5.34%
Operating Lease, Liability, Noncurrent 92M USD -16.4%
Other Liabilities, Noncurrent 638M USD +37.2%
Liabilities 6.97B USD -10.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -192M USD +64.6%
Retained Earnings (Accumulated Deficit) -1.87B USD +18.8%
Stockholders' Equity Attributable to Parent 6.78B USD +14%
Liabilities and Equity 13.7B USD -0.16%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4M USD -300%
Net Cash Provided by (Used in) Financing Activities 52M USD
Net Cash Provided by (Used in) Investing Activities -58M USD -257%
Common Stock, Shares Authorized 5B shares 0%
Common Stock, Shares, Issued 497M shares +0.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 19M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 539M USD +29.6%
Deferred Tax Assets, Valuation Allowance 269M USD -25.9%
Deferred Tax Assets, Gross 689M USD -15.5%
Operating Lease, Liability 123M USD -13.4%
Depreciation 25M USD +13.6%
Payments to Acquire Property, Plant, and Equipment 65M USD +171%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 784M USD
Lessee, Operating Lease, Liability, to be Paid 142M USD -13.4%
Property, Plant and Equipment, Gross 1.85B USD +0.54%
Operating Lease, Liability, Current 31M USD -3.13%
Lessee, Operating Lease, Liability, to be Paid, Year Two 30M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 37M USD -5.13%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) 2M USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 19M USD -13.6%
Lessee, Operating Lease, Liability, to be Paid, Year Three 22M USD -12%
Deferred Tax Assets, Operating Loss Carryforwards 180M USD -42.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1B shares 0%
Unrecognized Tax Benefits 40M USD +29%
Lessee, Operating Lease, Liability, to be Paid, Year Four 13M USD -18.8%
Additional Paid in Capital 8.84B USD +0.56%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 527M USD -2.77%
Depreciation, Depletion and Amortization 161M USD -3.01%
Deferred Tax Assets, Net of Valuation Allowance 420M USD -7.08%
Interest Expense 256M USD -5.88%